[1] PubMed ID: | 32323798 |
Disease Name: | Carcinoma, Non-Small-Cell Lung |
Sample: | NSCLC tissues |
Dysfunction Pattern: | interaction[sponges miR-328-5p] |
Validated Method: | qRT-PCR//Luciferase Report Assay//Western Blot |
Description: | In the present study, significant downregulation of TPTEP1 in tumors compared with normal tissues from patients with NSCLC was observed. Using a dual‑luciferase reporter assay and western blot analysis, it was further validated that TPTEP1 sponged miR‑328‑5p to upregulate Src kinase signaling inhibitor 1 (SRCIN1) in NSCLC cells. |
Causality: | Yes |
Causal Description: | Overexpression of TPTEP1 inhibited cell proliferation and induced apoptosis in NSCLC cells. |
Clinical-realted Application: | |
[2] PubMed ID: | 34539985 |
Disease Name: | Carcinoma, Non-Small-Cell Lung |
Sample: | NSCLC tissues |
Dysfunction Pattern: | Interaction(miR-761/LATS2 axis) |
Validated Method: | Western Blot//qRT-PCR//RIP//MTT//Luciferase Report Assay//Colony Formation Assay//Transwell Assay |
Description: | Compared with the normal adjacent tissues, the expressions of TPTEP1 and LATS2 were significantly down-regulated in the NSCLC tissues, while the expression of miR-761 was significantly increased. LATS2 was identified as a direct target of miR-761. Overexpression of miR-761 could significantly block the inhibitory effects of TPTEP1 on NSCLC, which clearly indicated that miR-761 played an oncogenic role in promoting proliferation and metastasis, while its downstream factor, LATS2, exerted opposite effects. |
Causality: | Yes |
Causal Description: | Overexpression of TPTEP1 exhibited substantial antitumor effects on NSCLC, including inhibition of cell proliferation and metastasis, which was achieved by targeting miR-761 and subsequently attenuated the expression of LATS2. |
Clinical-realted Application: | |
|